SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-067264
Filing Date
2019-11-26
Accepted
2019-11-26 08:45:56
Documents
15
Period of Report
2019-11-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1923664d1_8k.htm   iXBRL 8-K 56075
2 EXHIBIT 4.2 tm1923664d1_ex4-2.htm EX-4.2 1002407
3 EXHIBIT 4.13 tm1923664d1_ex4-13.htm EX-4.13 143250
  Complete submission text file 0001104659-19-067264.txt   1712004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA abbv-20191121.xsd EX-101.SCH 4481
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abbv-20191121_def.xml EX-101.DEF 30228
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE abbv-20191121_lab.xml EX-101.LAB 41943
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abbv-20191121_pre.xml EX-101.PRE 28431
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1923664d1_8k_htm.xml XML 9939
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 191247671
SIC: 2834 Pharmaceutical Preparations